FindTrial
Sign In

Clinical study of a novel coronavirus nucleic acid assay based on LAMP isothermal amplification

Clinical study of a novel coronavirus nucleic acid assay based on LAMP isothermal amplification

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200060048
Enrollment
Unknown
Registered
2022-05-16
Start date
2022-05-16
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Gold Standard:Nucleic acid fluorescence detection
Index test:Isothermal amplification technology realizes rapid bedside/home detection of 2019-nCoV

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 100 Years

Inclusion criteria

Inclusion criteria: Suspected COVID-19 cases.

Exclusion criteria

Exclusion criteria: Patients without the ability to authorize autonomously, unable to take samples or difficult to take samples due to nasal diseases.

Design outcomes

Primary

MeasureTime frame
2019-nCoV test results;Sensitivity;Specificity;Positive predictive value;Negative predictive value;—

Countries

China

Contacts

Public ContactLi Weimin
weimi003@yahoo.com+86 18980601009

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026